Compare Boston Scientific Corporation (BSX) vs Core Scientific Inc (CORZ) Price & Performance

Boston Scientific CorporationTrade

Core Scientific IncTrade

Price performance (Past 24H)

Key statistics

Boston Scientific Corporation vs Core Scientific Inc — how do they compare? Boston Scientific Corporation trades at $50.8 (market cap $74.19B), while Core Scientific Inc trades at $21.51 (market cap $6.35B). The key difference: Boston Scientific Corporation is far larger — about 11.7× Core Scientific Inc's market cap, and Core Scientific Inc is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.

	BSX	CORZ
Market Cap	$74.19B	$6.35B
Sector	Health	Technology
52-Week High	$108.14	$29.16
52-Week Low	$42.63	$13.55
Enterprise Value	$86.27B	$8.88B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Boston Scientific Corporation

BSX trades at $50.46, up 2.33% today, with strong earnings beats in recent quarters and a bullish technical trend. Revenue grew to $20.07B in 2025, with net income margin expanding to 17.5%. The stock shows robust institutional support and insider buying, while facing near-term headwinds from competitive pressures in key segments like WATCHMAN.

Outlook remains positive with 86% analyst buy ratings and a $67.21 consensus price target, implying 33% upside. Risks include guidance cuts and market share losses, but solid cash flow and valuation metrics support long-term growth potential for patient investors.

Core Scientific Inc

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BSX

Boston Scientific posts strong Q2 growth despite U.S. challenges, stock now valued attractively.Seeking Alpha · 1 day agoBullish Boston Scientific to present at Wells Fargo Healthcare Conference and report Q3 2026 results in OctoberPRNewsWire · 2 days agoNeutral View details →

CORZ

Neocloud stocks rise as NVIDIA-led $500B AI financing plan boosts data center buildout prospects24/7 Wall Street · 1 day agoBullish CoreWeave Q2 earnings expected in line; Jefferies eyes founder stock sales as next catalyst, profit gains months awayProactive Investors · 1 day agoBullish TeraWulf leads AI infrastructure stocks in 2026 with a 40.82% gain, driven by a major Anthropic lease deal.24/7 Wall Street · 1 day agoBullish View details →

About Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

About Core Scientific Inc

Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.